Member Info for LTbeliever

Seems everyone is busy trying to buy :))))

Once it hits 70p, speculators will notice and jump in so a quick rise to 80p will not be unreasonable IMO.

MIlls, I agree with you, logic suggests that a query was raised, NFX responded so the FDA Officer in charge should have quickly checked the response (unless it went down the pile, if you think pessimistically). If it was an unsatisfactory response, then FDA would - quickly IMO - issue a rejection; this is why I said "no news is good news". But, we cannot be 100% sure if this is indeed the case.

IMO, no news is "good news" insofar that we are not getting a NO from the FDA, leaving hopes for a YES (to ODD designation) alive. Clock ticking though for cash balances. Thus, either

1. Co is "relaxed" because they are aware of FDA's actions through US promoter, and "know" it's a matter of time to get ODD desgntn; in the meantime, (FFX pls forgive me!) they are talking to various partners, whilst planning for a small fund raise AFTER ODD is received,

OR 2. Co has no idea when / how the FDA will respond, and partners are dragging their feet with no end in sight.

3. any other ideas?

Laura, just to add that - re cash and b/ces - the Co spent 2mlnin capex in the prior fin. year, and expected to spend (as per last presentation) the "same amount" during this fin. year; assuming that as at eoDecember it had spent another 1mln (50%), it remains to be seen if / how this remaining capex will proceed. IMO, the Management will shed more light during the Interims and the subsequent presentation in appx 10 days. But this also means that the Co is 75% through its inv. programme i.e. 3mln spent in projects that are bound to reflect both in asset base increases and future profitability.

Definitely it'll be an exciting few days until the 17th Feb.

IMO, there are a lot of PIs and/or existing holders who want to buy in but - ST - are holding back, waiting to see if the 66p is/was the bottom; once the SP goes over 70-75p, more money will start flowing into the shares.

GB2, thanks for the summary; I recommend to LT holders to read the full Note, with the projections/numbers etc; the 250p is a "discounted" Target so yes, a lot of upside from 67p - almost 400% over, IMO, a 2 year horizon and by 2030 the projection estimates that the Co will have 10mln in CASH.

All it needs is a big industrial client (GE, Electric car, Robotics etc) to incorporate our sensors in its products, for things to take off as the tech will then be fully validated. IMO, the biggest STerm risk (fund raise) seems highly unlikely, based on these projections. DYOR, GLA.

FWIW, Cav...ndish have issued a revised TP of 250p, expect full recovery in a year or so, and forecasting that Cash should be sufficient. To access the Note, you need to be registered with Investor Meet, then answer a few questions by Cav..ish, to show you understand Investing risks. It's too early for me to copy the Note summary here, maybe another time :)

https://www.investormeetcompany.com/updates/transense-technologies-delays-impact-trading/show

D100, tnx for reminding about the Interims' closed period; there is a very good chance that the Co will take some actions by then, to reverse this drop IMO.

Just comparing 2022 numbers (when the SP was last at this level) with today, ie 5mln Revenues Vs 2ml and a Net profit of +1mln (+2mln spent on Capex inv.) Vs almost zero.

Could be an Inst Inv, a Director or the Co itself?

About 1% (thus far) of the Share capital was bought today; if we count out the 26% not in public hands then this % is even higher; and let's remember the 1.2mln shares held in Treasury (worth about GBP850.000 at today's SP), which can be sold to another big shareholder, should the Co ever need cash.

https://www.transense.com/investors/significant-shareholders

Whoever did the 30.000 x2 trades seems to agree with us. More to follow?

Highly probable, Laura - technically oversold and we know that downside is limited Vs the upside.

Looks like a big vote of confidence! @Laura, is it you??

I prefer a Director TBH. :) stronger signal to the market, IMO.

Although I am biased, I'm optimistic that the FDA designation is just a matter of time; and IMO, the Co is being very secretive about partners for valid commercial reasons, incl. protecting its IP, keeping some negot. leverage (despite possible "desperation, as some claim) if more than one etc. Time will tell and the potential rewards - if all the cards fall into place - may be substantial.

It seems healthcare will get more capital as a defensive sector now that the AI-crypto etc hype is causing some serious losses on all those speculators; UK and small caps should benefit once the "gold" dust settles down - IMO.

And if NFX too manages to get this ODD designation, then all be great! GLA.

Some people were selling @0.17 just 2 days ago, 40% lower than the Bid now. Maybe they are hoping to buy lower than 0.17?

0.2525 paid.

Thanks Laura, I'd rather put more money on TRT (and PIP!).